Altimmune names Jerry Durso as board chairman
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Altimmune Board of Directors Appoints Jerry Durso as Chairman
August 11, 2025 7:30 AM EDTAppointment recognizes Mr. Dursos extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH
Mitchel Sayare, Ph.D., to remain on the Board as Independent Director
GAITHERSBURG, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic... More



